Capital Advisory Group Advisory Services’s Bristol-Myers Squibb BMY Stock Holding History

Capital Advisory Group Advisory Services’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-8,148	Closed	-$367K	–	172
2025 Q3	$367K	Sell	8,148 -5,233	-39%	-$244K	0.11%	135
2025 Q2	$619K	Buy	13,381 +646	+5%	+$31.7K	0.22%	93
2025 Q1	$777K	Buy	12,735 +614	+5%	+$35.8K	0.3%	85
2024 Q4	$686K	Buy	12,121 +5,627	+87%	+$314K	0.25%	89
2024 Q3	$336K	Buy	+6,494	New	+$305K	0.13%	124
2023 Q4	–	Sell	-10,511	Closed	-$610K	–	145
2023 Q3	$610K	Sell	10,511 -215	-2%	-$13.2K	0.35%	70
2023 Q2	$686K	Buy	10,726 +236	+2%	+$15.8K	0.49%	51
2023 Q1	$727K	Buy	10,490 +69	+0.7%	+$4.87K	0.44%	66
2022 Q4	$750K	Sell	10,421 -75	-0.7%	-$5.66K	0.51%	56
2022 Q3	$746K	Buy	10,496 +5	+0%	+$363	0.52%	57
2022 Q2	$800K	Sell	10,491 -155	-1%	-$11.8K	0.48%	63
2022 Q1	$777K	Sell	10,646 -8	-0.1%	-$537	0.36%	76
2021 Q4	$664K	Sell	10,654 -1,910	-15%	-$112K	0.29%	81
2021 Q3	$743K	Buy	12,564 +676	+6%	+$44.5K	0.27%	91
2021 Q2	$794K	Buy	11,888 +2,047	+21%	+$133K	0.29%	87
2021 Q1	$621K	Buy	9,841 +4,353	+79%	+$271K	0.24%	97
2020 Q4	$340K	Buy	5,488 +3,840	+233%	+$236K	0.14%	118
2020 Q3	$99K	Buy	1,648 +593	+56%	+$35.7K	0.05%	176
2020 Q2	$62K	Buy	1,055 +32	+3%	+$1.91K	0.03%	190
2020 Q1	$56K	Buy	+1,023	New	+$62.5K	0.07%	108
2019 Q4	–	Sell	-1,023	Closed	-$51K	–	222
2019 Q3	$51K	Hold	1,023	–	–	0.03%	146
2019 Q2	$46K	Hold	1,023	–	–	0.03%	157
2019 Q1	$49K	Hold	1,023	–	–	0.04%	146
2018 Q4	$53K	Hold	1,023	–	–	0.04%	130
2018 Q3	$63K	Hold	1,023	–	–	0.04%	126
2018 Q2	$56K	Hold	1,023	–	–	0.04%	127
2018 Q1	$64K	Buy	+1,023	New	+$65.8K	0.05%	123

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Capital Advisory Group Advisory Services's BMY Position: Q4 2025 in Review

Capital Advisory Group Advisory Services sold out of Bristol-Myers Squibb (BMY) in Q4 2025, closing a stake of 8,148 shares — an estimated $367K sold.

Capital Advisory Group Advisory Services first reported a position in BMY in Q1 2018 and held it in 27 quarters. The position peaked at $800K in Q2 2022. 2,447 funds tracked by Wall St. Rank hold BMY as of Q4 2025.

Capital Advisory Group Advisory Services reported no remaining Bristol-Myers Squibb position as of Q4 2025 after selling out during the quarter.
Capital Advisory Group Advisory Services sold 8,148 Bristol-Myers Squibb shares in Q4 2025, an estimated $367K.
Capital Advisory Group Advisory Services first reported a position in Bristol-Myers Squibb in Q1 2018 and held it in 27 quarters.
Capital Advisory Group Advisory Services's Bristol-Myers Squibb position peaked at $800K in Q2 2022.
2,447 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2025.

Based on Capital Advisory Group Advisory Services's 13F filing for Q4 2025, filed 21 Jan 2026.